Dermata Therapeutics Inc. (DRMA)
NASDAQ: DRMA
· Real-Time Price · USD
5.41
0.01 (0.19%)
At close: Sep 12, 2025, 3:59 PM
5.60
3.61%
After-hours: Sep 12, 2025, 04:35 PM EDT
0.19% (1D)
| Bid | 5.04 |
| Market Cap | 3.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.33M |
| EPS (ttm) | 20.96 |
| PE Ratio (ttm) | 0.26 |
| Forward PE | -0.88 |
| Analyst | Buy |
| Ask | 5.7 |
| Volume | 22,647 |
| Avg. Volume (20D) | 21,975 |
| Open | 5.30 |
| Previous Close | 5.40 |
| Day's Range | 5.30 - 5.70 |
| 52-Week Range | 5.04 - 24.90 |
| Beta | 0.56 |
About DRMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+5.19%
Dermata shares are trading higher after the compan...
Unlock content with
Pro Subscription
9 months ago
+19.01%
Dermata Therapeutics shares are trading higher after the company received a notice of allowance for a U.S. patent titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS (INCLUDING ACNE)"
